Biotech is on the rise as drug companies seek to offset expiring patents and as investments are being made in new technologies such as genome and cancer research. Less money is going into clean energy and more into projects for efficient lighting and energy-management software.
Tim Mullaney, January 22, 2010 (Bloomberg) , writes:
"Venture-capital funding for startup companies stabilized in the fourth quarter, with investor interest shifting toward drug development and away from clean energy....
Biotech was the largest industry for the quarter."